The Developability Issues Affecting the Efficacy of Therapeutic Monoclonal Antibodies
Professor Charlotte Deane, University of Oxford, explains some of the barriers to efficacious therapeutic monoclonal antibodies.
We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Professor Charlotte Deane, University of Oxford, explains some of the barriers to efficacious therapeutic monoclonal antibodies.